Position in ROIV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,300
+$1,248 QoQ
Shares Held
65
+71.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#450
of 494 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rialto Wealth Management, LLC holds $899,727 across 71 Biotechnology names. ROIV ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MESO |
Mesoblast Ltd
|
46,500 | $629,145 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199 | $98,849 | |
| 3 | ABSI |
Absci Corp
|
2,044 | $23,689 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
52 | $19,326 | |
| 5 | PBLS |
Parabilis Medicines, Inc.
|
508 | $13,903 | |
| 6 | PBYI |
Puma Biotechnology, Inc.
|
1,450 | $11,759 | |
| 7 | SLN |
Silence Therapeutics plc
|
1,021 | $11,210 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
27 | $8,127 |
All Filings in ROIV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,300 | 65 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,052 | 38 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $651 | 30 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $166 | 11 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||